Oracle Validation Suite
Pharmacovigilance/Drug Safety systems provide the platform for collecting, assessing and reporting adverse event information to regulatory agencies electronically or via traditional paper based methodologies. Oracle AERS supports the capture, management, reporting, and analysis of serious adverse event and product compliance cases for all medical products including drugs, medical devices, vaccines, biologics, and gene therapies from all clinical and spontaneous sources.
USDM has developed a comprehensive solution to support Life Sciences companies with comprehensive testing of regulatory requirements for AERS. Our Validation Accelerator Package (VAP) provides validation assistance with core regulatory requirements for AERS and the Oracle Clinical Suite of products.
USDM's AERS VAP documentation provides a pre-configured content rich set of templates, ready for customization to meet both domestic and international regulations. Our documentation templates include:
- Validation Plan
- User Requirements Template
- Risk Assessment
- Functional and Design Specification
- Installation Qualification
- Operational Qualification
- Performance Qualification Template
- Trace Matrix
- Validation Summary Report
USDM identifies upcoming patches and updates and provides a full maintenance program for our AERS clients. Recommendations for required testing are made to ensure our clients an effective, efficient validation maintenance process.
To learn more about USDM and how we can assist with your compliance and business objectives, please contact:
Rebecca Meledy
888.231.0816 x161
775.213.5943 (fax)
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
This e-mail address is being protected from spambots. You need JavaScript enabled to view it This e-mail address is being protected from spambots. You need JavaScript enabled to view it
"Simplify, Unify and Optimize your business & compliance needs with USDM"
